Combinations to Dominate 2017 for Immunotherapy

Combinations to Dominate 2017 for Immunotherapy

User Photo
AnnualMeeting-SITC2017

3 years
1,237 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Ezra E.W. Cohen, MD of University of California, San Diego states that in 2017, we will see more combination immuno-therapy for cancer treatment. This was recorded at the ASCO-SITC Clinical Immuno-Oncology Symposium in Orlando, Florida.
Up Next Autoplay
>